On July 24, 2019, Bonacucina, Giulia; Cespi, Marco; Casettari, Luca; Torregiani, Elisabetta; Logrippo, Serena; Palmieri, Giovanni Filippo; Perinelli, Diego Romano; Ganzetti, Roberta; Sestili, Matteo published a patent.Application of 86393-32-0 The title of the patent was Gel formulations containing water-soluble active ingredients for oral administration of drugs in patients with dysphagia. And the patent contained the following:
A pharmaceutical gel formulation is disclosed containing water soluble therapeutically active ingredient which are generally available only as oral solid dosage forms or tablets and/or capsules and/or immediate release powders or granules, which can be administered in the presence of abnormalities in the swallowing process. The experimental process involved the reaction of 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate(cas: 86393-32-0).Application of 86393-32-0
The Article related to formulation gel oral dysphagia tablet capsules powder granule pharmaceutical, Pharmaceuticals: Formulation and Compounding and other aspects.Application of 86393-32-0
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics